Clinical development of products for specific immunotherapy for the treatment of allergic diseases

Current effective version

PDF iconAdopted guideline

Reference numberCHMP/EWP/18504/06
Effective from01/06/2009
KeywordsAllergic disease, specific immunotherapy, allergic rhinoconjunctivitis
DescriptionThis document provides guidance for the development of studies of products for specific immunotherapy to enhance the assessment and comparison of results of such studies.

Document history

First version

Current version

PDF iconAdopted guideline

Overview of comments

Draft guideline

PDF iconConcept paper

In operation: 01/06/2009–present

Published: 23/06/2008

Published: 24/05/2007

Published: 26/01/2006

Related content

How useful was this page?

Add your rating